-- ディオス・エクスプロレーション（DOS.V）は水曜日、AU33ヘベルト金鉱床の探査開始にあたり、地表近くの金を含む珪化カリウム断層帯に沿って約2,000メートルのダイヤモンド掘削を実施したと発表し、必要な許可をすべて取得したことを確認した。 同社はまた、金価格は現在「非常に稀な高値水準にあり、2015年から2017年にかけてディオスがヘベルト金鉱床を初めて掘削して発見して以来、驚異的な上昇を見せている」と付け加えた。 「ディオスは現在ヘベルト金鉱床に注力しているが、他にも複数の地表エリアで掘削が必要だ。このディオスの主力高ポテンシャル金鉱床は、2025年後半にドローン磁気探査を実施し、詳細な構造を把握した上で、2026年に予定されている地上アクセス型ダイヤモンド掘削の準備を進めている」と声明で述べた。 同社の株価は、トロント証券取引所ベンチャー市場で0.005ドル高の0.035ドルで取引されている。
Price: $0.04, Change: $+0.01, Percent Change: +16.67%
Primaris Real Estate Investment Trust (PMZ-UN.TO) after trade Wednesday reported higher total rental revenue and profit for the first quarter and reaffirmed its 2026 outlook.The REIT earned $41.9 million, or $0.305 per unit, in the period, up from $31.2 million, or $0.257, a year ago. Corresponding FactSet figures were not available.Total rental revenue rose to $177.04 million from $150.2 million a year prior. FactSet expected sales of $180.8 million.Among other highlights, Primaris cited funds from operations per average diluted unit of $0.425 compared with $0.439 a year ago. FactSet projected FFO per share of $0.44."Our low leverage, low payout ratio model is a critical pillar to our strategy. We have significant liquidity with the full availability on our unsecured credit facility with no debt maturing in 2026, Chief Financial Officer Rags Davloor said."With strong liquidity, very low leverage, and a low payout ratio, we are well positioned to fund internal growth, enhance portfolio quality, and create long term value for our unitholders," Chief Executive Alex Avery added.The REIT said it is maintaining its full-year 2026 guidance.The REIT's units closed down $0.05 to $18.98 on the Toronto Stock Exchange.
Anatol Kreitzer, Chief Discovery Officer, on April 27, 2026, sold 45,422 shares in Maplight Therapeutics (MPLT) for $1,347,066. Following the Form 4 filing with the SEC, Kreitzer has control over a total of 211,190 voting common shares of the company, with 211,190 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123826000008/xslF345X05/form4-04292026_040429.xml
Jonathan Gillis, Chief Administrative and Accounting Officer and Principal Accounting Officer, on April 27, 2026, sold 69,835 shares in Maplight Therapeutics (MPLT) for $2,087,687. Following the Form 4 filing with the SEC, Gillis has control over a total of 181,219 voting common shares of the company, with 181,219 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000170995426000008/xslF345X05/form4-04292026_040431.xml